CompletedNot Applicable

CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women

United States10 participantsStarted 2019-04-01

Plain-language summary

CO2 laser energy is currently used widely for the treatment of postmenopausal women who have vaginal atrophy due to the lack of estrogen. However, its effect on premenopausal women with hormonally-mediated vulvar vestibulodynia is unknown. This study seeks to evaluate the effect of CO2 laser on young women and compare it to topical lidocaine.

Who can participate

Age range

18 Years – 40 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years to 40 years * Hormonal contraceptive therapy for at least one year consecutive duration * Vestibulodynia diagnosis meeting the following criteria: * Localized vulvar pain to vaginal vestibule * At least 3 months duration * Without clear identifiable cause Exclusion Criteria: * Suspected primary cause to vestibular pain that warrants directed treatment * History of chronic infection or autoimmune disease * Prior pelvic surgery including mesh placement for incontinence or prolapse, vestibulectomy, vulvectomy, or labiaplasty * Active vulvar or vaginal infection * Allergy or contraindication to topical lidocaine treatment * Prior diagnosis or treatment of vulvar intraepithelial neoplasia or vulvar malignancy

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

VAS

Timeframe: 3 months

Trial details

NCT IDNCT05336825

SponsorAtlantic Health System

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-01-31

View on ClinicalTrials.gov More Vulvodynia trials